Louise Nilsson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Louise Nilsson has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Charlotte Ling
Epigenetics and Diabetes Unit, Department of Clinical Sciences in Malmö, Lund University, Scania University Hospital, Malmö, Sweden
2 shared publications - Håkan Billig
Department of Physiology/Endocrinology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, 40530, Gothenburg, Sweden
2 shared publications Anders H. Olsson
Department of Clinical Sciences, Lund University Diabetes Center, CRC, Lund University, University Hospital MAS, 205 02 Malmö, Sweden
1 shared publication- Bente Kiens
University of Copenhagen
1 shared publication Bo Isomaa
Malmska Municipal Health Center and Hospital, Jakobstad, Finland
1 shared publicationC. Roepstorff
1 shared publication
Latest Publications
- 1 January 2011
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 102 (1) , 78-81
A common variant near the PRL gene is associated with increased adiposity in males
- 1 January 2011
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 102 (1) , 78-81
A common variant near the PRL gene is associated with increased adiposity in males
- 23 June 2009
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 41 (10) , 747-751
Prolactin Suppresses Malonyl-CoA Concentration in Human Adipose Tissue
Prolactin is best known for its involvement in lactation, where it regulates mechanisms that supply nutrients for milk production. In individuals with pathological hyperprolactinemia, glucose and fat homeostasis have been reported to be negatively influenced. It is not previously known, however, whether prolactin regulates lipogenesis in human adipose tissue. The aim of this study was to investigate the effect of prolactin on lipogenesis in human adipose tissue in vitro. Prolactin decreased the concentration of malonyl-CoA, the product of the first committed step in lipogenesis, to 77±6% compared to control 100±5% (p=0.022) in cultured human adipose tissue. In addition, prolactin was found to decrease glucose transporter 4 (GLUT4) mRNA expression, which may cause decreased glucose uptake. In conclusion, we propose that prolactin decreases lipogenesis in human adipose tissue as a consequence of suppressed malonyl-CoA concentration in parallel with decreased GLUT-4 expression. In the lactating woman, this regulation in adipose tissue may enhance the provision of nutrients for the infant instead of nutrients being stored in adipose tissue. In hyperprolactinemic individuals, a suppressed lipogenesis could contribute to an insulin resistant state with consequences for the health.
- 23 June 2009
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 41 (10) , 747-751
Prolactin Suppresses Malonyl-CoA Concentration in Human Adipose Tissue
Prolactin is best known for its involvement in lactation, where it regulates mechanisms that supply nutrients for milk production. In individuals with pathological hyperprolactinemia, glucose and fat homeostasis have been reported to be negatively influenced. It is not previously known, however, whether prolactin regulates lipogenesis in human adipose tissue. The aim of this study was to investigate the effect of prolactin on lipogenesis in human adipose tissue in vitro. Prolactin decreased the concentration of malonyl-CoA, the product of the first committed step in lipogenesis, to 77±6% compared to control 100±5% (p=0.022) in cultured human adipose tissue. In addition, prolactin was found to decrease glucose transporter 4 (GLUT4) mRNA expression, which may cause decreased glucose uptake. In conclusion, we propose that prolactin decreases lipogenesis in human adipose tissue as a consequence of suppressed malonyl-CoA concentration in parallel with decreased GLUT-4 expression. In the lactating woman, this regulation in adipose tissue may enhance the provision of nutrients for the infant instead of nutrients being stored in adipose tissue. In hyperprolactinemic individuals, a suppressed lipogenesis could contribute to an insulin resistant state with consequences for the health.